리스페리돈과 올란자핀이 투여된 정신과 환자들에서 간 효소 변화에 대한 후향적 연구
Retrospective Study on Hepatic Enzyme Changes in Patients Treated with Risperidone and Olanzapine
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Abstract
Objectives：Hetapic dynfunction caused by the use of atypical antipsychotics in patients with psychiatric disorders has not been frequently reported compared to the use of typical antipsychotics. This retrospective study was aimed at assessing the differences of hepatic dysfunctions between patients treated with risperidone and olanzapine through reviewing computerizedmedical records. Methods：Charts of 667 risperidone- and olanzapin treated patients hospitalized at the department of psychiatray, Kangnam St. Mary’s Hostpital, between 1998 and 2002, were reviewed. The frequencies of hepatic enzyme elevation in association with clinical variables such as time course of the use of antipsychotics were analyzed . Results：Significant elevation in alanine aminotransferase (ALT) to upper reference range and 2 fold range were seen in olanzapine monotherapy patients, but not in risperidone monotherapy group. There was no difference between olanzapine and risperidone monotherapy groups in time course of hepatic dysfunction. There was no difference in hepatic enzyme elevation between resperidon and olanzapine combination therapy groups. Conclusion：The results suggest potential difference in degree of antipsychotic induced hepatic dysfunction between risperidone and olanzapine treatment. Well-desigend prospective study would be nessassary to extend our putative results. (J Korean Neuropsychiatr Assoc 2004;43(3):283-287)
참고문헌 (20)
- "Update of hepatotoxicity due to classes of drugs incommon clinical use", (n-steroidal drugs), pp.322~338
- "Drug induced hepatotoxicity", 104, pp.826~839 (1986)
- "Neuroleptic-induced priapism,hepatotoxicity ansubsequent impotence in a patient with depressive psychosis", 157, pp.759~762 (1990)
- "Hepatotoxicity of clozapine", 17, pp.314~317 (1997)
- "Risperdal (risperidone) prescribing information" (2001)
- "Zyprexa (olanzapine) prescribing information" (2000)
- "Risperidone 투여로 유발된 간독성 1예", 38, pp.1522~1526 (1999)
- "Rapid onset of risperisone inducedhepatotoxicity", 32, pp.843~ (1998)
- "Risperidone induced cholestatic hepatitis", 13, pp.67~69 (2001)
- "Physician’s Desk Reference？" (2002)
- "Hepatotoxicity of Psychotropic Drugs", 29, pp.1347~1351 (1999)
- "Drug induced hepatotoxicity", 33, pp.1118~1127 (1995)
- "Relevance of LiverEnzyme Elevations With four Different Neuroleptics ; a retrospectivereview of 7,263 treatment courses J clin psychopham", 21, pp.215~222 (1999)
- "Risperidone in the treatment of schizophreniaAm J Psychiatry 1994", pp.824~835
- "Risperidone-associated hepatotoxicity", 16, pp.84~ (1996)
- "Jaundice associated with theuse of risperidone in a case of presenile dementia", 11, pp.177~ (1996)
- "Olanzapine;An update reviewof its use in the management of schizophrenia Drug", 61, pp.111~161 (2001)
- "Olanzapine versus palcebo andhaloperidol:acute phase results of the North American double-blindolanzapine trial", 14, pp.111~123 (1996)
- "Olanzapine versus placebo:results of double blind fixed dose olanzapine trial Psychopharmacology", 124, pp.159~167 (1996)
- "A case reportof olanzapine-induced hypersensitivity syndrome", 321, pp.156~158 (2001)